MMP19
Basic information
Region (hg38): 12:55835433-55842966
Previous symbols: [ "MMP18" ]
Links
Phenotypes
GenCC
Source:
- familial cavitary optic disk anomaly (Limited), mode of inheritance: Unknown
- familial cavitary optic disk anomaly (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cavitary optic disc anomalies | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 17368552; 17362864; 25581579 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMP19 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 40 | 51 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 40 | 11 | 6 |
Variants in MMP19
This is a list of pathogenic ClinVar variants found in the MMP19 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-55837062-C-T | not specified | Uncertain significance (May 15, 2024) | ||
12-55837101-G-T | Benign (Dec 31, 2019) | |||
12-55837113-C-T | Likely benign (Dec 21, 2018) | |||
12-55837124-G-T | not specified | Uncertain significance (Jul 14, 2021) | ||
12-55837125-T-C | not specified | Uncertain significance (Dec 17, 2021) | ||
12-55837139-C-T | not specified | Likely benign (Nov 13, 2024) | ||
12-55837140-G-A | not specified | Uncertain significance (Jan 10, 2022) | ||
12-55837146-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
12-55837146-G-C | not specified | Uncertain significance (Feb 28, 2023) | ||
12-55837196-C-T | Likely benign (Dec 31, 2019) | |||
12-55837214-C-T | not specified | Uncertain significance (Aug 12, 2024) | ||
12-55837215-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
12-55837239-A-T | not specified | Uncertain significance (May 23, 2023) | ||
12-55837241-T-C | not specified | Uncertain significance (Nov 22, 2024) | ||
12-55837308-T-C | not specified | Uncertain significance (Jun 22, 2021) | ||
12-55837583-G-A | not specified | Uncertain significance (May 03, 2024) | ||
12-55837588-A-T | Interstitial lung disease 2 | Uncertain significance (May 06, 2018) | ||
12-55837591-G-A | Benign (May 18, 2018) | |||
12-55837604-A-G | not specified | Uncertain significance (Mar 31, 2024) | ||
12-55837605-G-C | not specified | Uncertain significance (May 02, 2024) | ||
12-55837875-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
12-55837975-C-T | not specified | Likely benign (Jul 26, 2024) | ||
12-55837984-A-G | not specified | Uncertain significance (Nov 01, 2022) | ||
12-55838002-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
12-55838617-G-A | not specified | Uncertain significance (Oct 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMP19 | protein_coding | protein_coding | ENST00000322569 | 9 | 7534 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.00e-20 | 0.000880 | 125411 | 0 | 337 | 125748 | 0.00134 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.363 | 284 | 302 | 0.941 | 0.0000173 | 3268 |
Missense in Polyphen | 122 | 124.28 | 0.98164 | 1366 | ||
Synonymous | 0.235 | 115 | 118 | 0.973 | 0.00000670 | 1024 |
Loss of Function | -0.366 | 29 | 27.0 | 1.08 | 0.00000156 | 257 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00183 | 0.00183 |
Ashkenazi Jewish | 0.000397 | 0.000397 |
East Asian | 0.00250 | 0.00245 |
Finnish | 0.000418 | 0.000416 |
European (Non-Finnish) | 0.00183 | 0.00182 |
Middle Eastern | 0.00250 | 0.00245 |
South Asian | 0.000333 | 0.000327 |
Other | 0.00196 | 0.00196 |
dbNSFP
Source:
- Function
- FUNCTION: Endopeptidase that degrades various components of the extracellular matrix, such as aggrecan and cartilage oligomeric matrix protein (comp), during development, haemostasis and pathological conditions (arthritic disease). May also play a role in neovascularization or angiogenesis. Hydrolyzes collagen type IV, laminin, nidogen, nascin-C isoform, fibronectin, and type I gelatin. {ECO:0000269|PubMed:10809722, ECO:0000269|PubMed:10922468}.;
- Disease
- DISEASE: Cavitary optic disc anomalies (CODA) [MIM:611543]: An ocular disease characterized by a profound excavation of the optic nerve. Clinical phenotype is variable and includes congenitally excavated optic nerves as well as other features of optic pit, optic nerve coloboma, and morning glory disk anomaly. Patients with CODA have a strong predilection for retinal detachment and/or separation of the retinal layers (retinoschisis) that lead to profound central vision loss. {ECO:0000269|PubMed:25581579}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Matrix Metalloproteinases;Extracellular matrix organization;Degradation of the extracellular matrix
(Consensus)
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- rvis_EVS
- -0.13
- rvis_percentile_EVS
- 44.03
Haploinsufficiency Scores
- pHI
- 0.442
- hipred
- N
- hipred_score
- 0.153
- ghis
- 0.481
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.206
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mmp19
- Phenotype
- immune system phenotype; hematopoietic system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); neoplasm; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- angiogenesis;ovarian follicle development;ovulation from ovarian follicle;luteolysis;proteolysis;response to hormone;extracellular matrix disassembly;cell differentiation;extracellular matrix organization;collagen catabolic process;response to cAMP
- Cellular component
- extracellular region;extracellular space;extracellular matrix
- Molecular function
- metalloendopeptidase activity;serine-type endopeptidase activity;zinc ion binding